fbpx European and Italian research in food and agriculture sector | Science in the net

European and Italian research in food and agriculture sector

Primary tabs

Read time: 3 mins

“The food and drink industry is the largest manufacturing industry in the European Union, generating turnover of €956 billion in 2010”, as claimed by the European Union itself. More than four millions Europeans work inside one of the 310.000 food enterprises (both primary and transforming). Nonetheless, 95% of these firms are composed by small or medium enterprises, which have less than 20 workers. In other words, they are too small to carry on strategic R&D policies: investments in the food R&D sector represent just 1.05% of the entire net turnover.

Despite being fragmented and investing so little, since 2010 the European Union is a net exporter of agricultural products, mostly final products. We have a profitable food industry, but with low investments in R&D. Moreover, experts say that a large amount of greenhouse gasses production comes from the food sector. Given these figures, the European Union is trying to solve this paradox through Horizon 2020. Will Italy take the opportunity?

Horizon 2020

The European Union has prospected to invest €248 million in 2014 and 2015 in food and drink industry through Horizon 2020, the new research investment program. At first sight, €248 million could seem an enormous budget. But actually, looking at the figures, it is not: the EU will spend just 5% of the 2014 budget in food and agricultural researches.

Anyway, the food issue is housed in the Horizon 2020's “Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy” program. The program's aim is to “contribute to securing sufficient supplies of safe, healthy and high quality food and other bio-based products, by developing productive, sustainable and resource-efficient primary production systems, fostering related ecosystem services and the recovery of biological diversity, alongside competitive and low carbon supply chains. This will accelerate the transition to a sustainable European bioeconomy, bridging the gap between new technologies and their implementation”. The effort is based on the fact that most of the entire supply chain in food industry is made by small and medium enterprises, which suffered the most from European economic turbulences. Someone could say that Horizon 2020, in this sector, is another way to subsidize agriculture and food industry – an issue that has always created problems with non-EU partners.

Italy between European grants and the Milan Expo 2015

Will Italy take advantage of Horizon 2020? Looking at past experiences, the answer would seem to be “no”. Italian food industry reflects the average European situation: 96% of the business is carried on by small and medium enterprises (similar to France, but higher than UK and Germany). Often, in Italy, the food issue is linked with cultural matters: Italian traditional cuisine is famous all over the world, and is known for being particularly healthy. But consumers’ habits are changing, as 26% of Italian teenagers (5-17 years old) suffer a form of obesity. Biotechnology and other innovation in the sector could improve business performances and fight obesity, but actually the efforts of the Italian institutions towards these two goals are weak.

The Italian participation in the food sector of the 7th Framework Program had been very frail. The success rate of Italian coordinators' approved proposals had been just 9%, putting Italy as the fifth country after UK, France, Germany and Netherlands. Universities have been the 66% of the winning coordinators, underlying the fact that small enterprises cannot or do not want to carry on research in food industry: as a matter of fact, none of the Italian enterprises in the sector have won a grant as coordinator.

As said before, Italy is the place where food and agriculture are the baselines of the national identity. Rejecting the advantage of this great tradition during H2020 will be not only a missed opportunity for Italian researchers, but a heavy loss in terms of health, innovation and economical revenues. The new Minister of the Agriculture Policies, Maurizio Martina, has a great opportunity to make the difference. Especially now, as Milan will host the Expo 2015, which is focused on the food issue.


Scienza in rete è un giornale senza pubblicità e aperto a tutti per garantire l’indipendenza dell’informazione e il diritto universale alla cittadinanza scientifica. Contribuisci a dar voce alla ricerca sostenendo Scienza in rete. In questo modo, potrai entrare a far parte della nostra comunità e condividere il nostro percorso. Clicca sul pulsante e scegli liberamente quanto donare! Anche una piccola somma è importante. Se vuoi fare una donazione ricorrente, ci consenti di programmare meglio il nostro lavoro e resti comunque libero di interromperla quando credi.


prossimo articolo

My Portrait of Anthony Fauci

Anthony Fauci, at 85, has been called to testify before the Senate committee investigating the origins of the Covid-19 pandemic, in what feels like a settling of scores by the very party that, at the time, was recommending chloroquine as a defence. The eminent physician is once again at the centre of controversy, not least for choosing to invoke the Fifth Amendment rather than answer questions. Guido Poli, immunologist at the San Raffaele Hospital and president of Patto Trasversale per la Scienza, who worked with him for many years, recalls in this article Tony Fauci's battles in the history of American and international public health, from AIDS to the pandemic. The image is taken from the footage (public domain) of A. Fauci's hearing on 29 July 2026 before the Senate Homeland Security and Governmental Affairs Committee.

In recent days, Anthony (“Tony”) Fauci has once again become a prominent figure in the international media, and to some extent in Italy as well. As the physician-scientist who has played one of the leading roles in U.S. public health over the past several decades, he became known throughout the world during the darkest days of the COVID-19 pandemic. Having had the privilege and good fortune to work with him from 1986 to 1993, I would like to offer my personal account of the scientist and the man.